CMLAB
CMLAB is a South Korean medical technology company specializing in electroceutical treatments for age-related macular degeneration (AMD) and other retinal diseases. The company develops innovative therapies using Multi-PhotoBioModulation Therapy (mPBMT), a novel electroceutical technology that enhances mitochondrial function and antioxidant activity to treat dry AMD, a condition with no existing effective treatments. CMLAB also offers AI-based eye disease screening through its EYEJOY product and photodynamic therapy with COVELITE. The company is recognized by the South Korean Ministry of Health and Welfare for its research and development in electroceutical technology. Its business model includes product sales and technology licensing, targeting ophthalmology clinics and healthcare providers. CMLAB is positioned as a pioneer in electroceutical therapies for retinal diseases with a focus on innovative, non-invasive treatments.
CMLAB
CMLAB is a South Korean medical technology company specializing in electroceutical treatments for age-related macular degeneration (AMD) and other retinal diseases. The company develops innovative therapies using Multi-PhotoBioModulation Therapy (mPBMT), a novel electroceutical technology that enhances mitochondrial function and antioxidant activity to treat dry AMD, a condition with no existing effective treatments. CMLAB also offers AI-based eye disease screening through its EYEJOY product and photodynamic therapy with COVELITE. The company is recognized by the South Korean Ministry of Health and Welfare for its research and development in electroceutical technology. Its business model includes product sales and technology licensing, targeting ophthalmology clinics and healthcare providers. CMLAB is positioned as a pioneer in electroceutical therapies for retinal diseases with a focus on innovative, non-invasive treatments.